ketanserin has been researched along with urapidil in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 9 (45.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baldanzi, G; Bertoni, A; Capello, D; Fresu, LG; Gesu, A; Graziani, A; Massarotti, A; Ruffo, E; Snow, AL; Talmon, M; Tron, GC; Varma, KSS; Velnati, S | 1 |
| Blauw, GJ; van Brummelen, P; van Zwieten, PA | 3 |
| Lauwers, P; Möllhoff, T; Mulier, JP; Müller, E; Van Aken, H | 1 |
| Kirsten, R; Ochs, JG; Storck, J | 1 |
| Prichard, BN; Van Zwieten, PA | 1 |
| van Zwieten, PA | 1 |
| Doyle, AE | 1 |
| Timmermans, PB; van Zwieten, PA | 1 |
| Timmermans, PB; Van Brummelen, P; Van Zwieten, PA | 1 |
| Baumgärtel, M; Petry, A; Wulf, H | 1 |
| Innes, PA | 1 |
| Kal, JE; Kooyman, J; Korsten, HH; Langemeijer, JJ; Porsius, M; van den Ende, R; van der Starre, PJ; van der Stroom, JG; van Wezel, HB; van Zwieten, PA | 1 |
| Petry, A | 1 |
| Buñag, RD; Mellick, JR; Thomas, CV | 1 |
7 review(s) available for ketanserin and urapidil
| Article | Year |
|---|---|
Serotonergic receptors and drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Humans; Hypertension; Ketanserin; Piperazines; Receptors, Serotonin; Vasodilator Agents | 1992 |
Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Ketanserin; Piperazines; Receptors, Serotonin; Serotonin Antagonists | 1990 |
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
Topics: Animals; Antihypertensive Agents; Cardiovascular Diseases; Humans; Hypertension; Ketanserin; Piperazines; Receptors, Serotonin; Serotonin | 1990 |
Basic pharmacology of alpha-adrenoceptor antagonists and hybrid drugs.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Chemical Phenomena; Chemistry; Humans; Ketanserin; Labetalol; Piperazines | 1988 |
Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Ketanserin; Labetalol; Piperazines | 1988 |
Cardiovascular alpha 2-receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Affinity Labels; Animals; Blood Pressure; Brain; Calcium Channel Blockers; Cardiovascular Physiological Phenomena; Guanosine Triphosphate; Heart Rate; Humans; Ketanserin; Kidney; Muscle, Smooth, Vascular; Piperazines; Piperidines; Prazosin; Receptors, Adrenergic, alpha; Synaptic Membranes; Tritium; Vasoconstriction | 1983 |
Role of alpha adrenoceptors in hypertension and in antihypertensive drug treatment.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Azepines; Blood Pressure; Calcium Channel Blockers; Clonidine; Guanfacine; Guanidines; Humans; Hypertension; Ketanserin; Methyldopa; Muscle, Smooth, Vascular; Phenylacetates; Piperazines; Piperidines; Prazosin; Radioligand Assay; Receptors, Adrenergic, alpha; Vascular Resistance | 1984 |
4 trial(s) available for ketanserin and urapidil
| Article | Year |
|---|---|
Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting.
Topics: Antihypertensive Agents; Coronary Artery Bypass; Heart Rate; Hemodynamics; Humans; Hypertension; Ketanserin; Middle Aged; Nitroprusside; Oxygen; Piperazines; Postoperative Complications; Respiration | 1990 |
The influence of ketanserin or urapidil on haemodynamics, stress response and kidney function during operations for myocardial revascularisation.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anesthesia, General; Antihypertensive Agents; Double-Blind Method; Epinephrine; Hemodynamics; Humans; Hypertension; Ketanserin; Kidney; Male; Middle Aged; Myocardial Revascularization; Norepinephrine; Piperazines; Prospective Studies | 1995 |
A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
Topics: Aged; Antihypertensive Agents; Coronary Vessels; Double-Blind Method; Hemodynamics; Humans; Hypertension; Ketanserin; Middle Aged; Piperazines; Postoperative Complications; Respiration | 1997 |
Computer aided monitor-data processing (CAMP). A landmark for unbiased gauging of anaesthetic courses?
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Anesthesia, General; Blood Pressure; Hemodynamics; Humans; Ketanserin; Male; Medical Records Systems, Computerized; Middle Aged; Monitoring, Intraoperative; Myocardial Revascularization; Operating Room Information Systems; Piperazines; Prospective Studies; Serotonin Antagonists | 1998 |
9 other study(ies) available for ketanserin and urapidil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lymphoproliferative Disorders; Piperidines; Protein Kinase Inhibitors; Pyrimidinones; Quinazolinones; Ritanserin; Thiazoles | 2019 |
Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
Topics: Administration, Oral; Adult; Blood Platelets; Carbon Radioisotopes; Epinephrine; Humans; Ketanserin; Nafronyl; Piperazines; Platelet Aggregation Inhibitors; Prazosin; Serotonin; Serotonin Antagonists | 1990 |
An antihypertensive drug with polyfactor mechanism of action: urapidil.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Chemistry; Cats; Humans; Ketanserin; Labetalol; Piperazines; Rats; Receptors, Adrenergic; Receptors, Serotonin | 1989 |
Ketanserin and urapidil during myocardial revascularisation.
Topics: Hemodynamics; Humans; Ketanserin; Myocardial Revascularization; Piperazines; Research Design; Vasodilator Agents | 1995 |
Ketanserin versus urapidil: age-related cardiovascular effects in conscious rats.
Topics: Aging; Angiotensins; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradycardia; Ketanserin; Male; Piperazines; Rats; Rats, Sprague-Dawley; Reflex | 2002 |